ghSMART Deepens its Presence in Australia to Further Serve Top Business Leaders
SYDNEY, March 31, 2025 /PRNewswire/ -- ghSMART has been serving Australian clients for 25 years, partnering with global businesses, leading private equity firms, and boards committed to leadership excellence. As part of its continued global...
Li-S Energy collaborates with Kea Aerospace to power high altitude UAV flights
SYDNEY, March 31, 2025 /PRNewswire/ -- Li-S Energy (ASX:LIS) ('Li-S' or 'the Company') has signed a collaboration agreement with Kea Aerospace (Kea) to integrate Li-S' advanced lithium sulfur battery technology into Kea's high altitude UAVs...
CNOOC Limited Announces A Hundred-Million-Ton Oilfield Discovery of Huizhou 19-6
HONG KONG, March 31, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that the Company has made a major oilfield discovery of Huizhou 19-6 in the deep and ultra-deep...
Patent Index 2024: Japan ranks 3rd in European patent applications
European Patent Office received nearly 200 000 patent applications last year, with Japanese companies and inventors filing 10.6% of the total Electrical machinery/energy, transport and computers are leading technology fields for Japanese inventions...
Roborock Unveils Groundbreaking Saros Series in Australia
Featuring World-First Robotic Arm Technology and Smarter, Slimmer Cleaning for Aussie Homes SYDNEY, March 31, 2025 /PRNewswire/ -- Roborock, a global leader in ultra-intelligent home robotics, today announced the arrival of its revolutionary Saros...
AWP Services New Zealand Limited t/a Allianz Partners forges a strategic partnership with Mitsui Sumitomo Insurance Company, Limited
AUCKLAND, New Zealand, March 31, 2025 /PRNewswire/ -- Allianz Partners New Zealand and Mitsui Sumitomo Insurance Company Limited New Zealand Branch ("MSI NZ"), a member of MS&AD Insurance Group, are excited to announce a multi-year agreement,...
Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies
Key Highlights: Global first "immuno + anti-vascular" bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study topline data expected mid-2025 (FDA FTD). ivonescimab outperforms pembrolizumab in Phase III...
Global Times: Practitioners' Insights: Practice of 'feedback window for unfinished work' in Anji showcases CPC's people-centric approach
BEIJING, March 31, 2025 /PRNewswire/ -- Government service halls across many regions in China have established dedicated feedback windows for handling unfinished work. What is such window? Out of the curiosity, the Global Times recently visited the...